Clinical trial
Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
NCT00299013 · Alizyme, Industry · Completed
Key facts
| NCT number | NCT00299013 |
|---|---|
| Title | Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis |
| Official title | A Multicentre, Randomised, Double Blind, Double Dummy, Active Comparator Controlled, Parallel Group Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis |
| Lead sponsor | Alizyme, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Drug |
| Interventions | COLAL-PRED®, Prednisolone |
| Enrollment | 796 |
| Start date | Mar 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Mar 6, 2006 |
| Last update posted | Apr 25, 2008 |
| Countries | Australia, Belgium, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Poland, Russia, South Africa and 3 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: